BAY 43-9006 Inhibition of Oncogenic RET Mutants
Francesca Carlomagno(Institute for Experimental Endocrinology and Oncology), Massimo Santoro(University of Padua)
Cited by 471
Related Papers
ROS homeostasis and metabolism: a dangerous liason in cancer cells
|Cell Death and Disease|2016|1.1k
Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth Factor Receptor β Gatekeeper Mutants
|Clinical Cancer Research|2007|73
The crosstalk between metabolism and translation
|Cell Metabolism|2024|44
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474
|Endocrine Related Cancer|2008|40
The circadian protein BMAL1 supports endothelial cell cycle during angiogenesis
|Cardiovascular Research|2023|39